Avidity Biosciences
RNA
$24.36
Share price
2.22%
Change (1 day)
67.42%
Change (1 year)
Categories
Avidity Biosciences (RNA) - Net assets
Net assets on the balance sheet as of December 2023 : $0.50 B
According to Avidity Biosciences's latest financial reports the company has $0.50 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Avidity Biosciences - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.50 B | -13.37% |
| 2022-12-31 | $0.57 B | 51.55% |
| 2021-12-31 | $0.38 B | 24.56% |
| 2020-12-31 | $0.30 B | -568.54% |
| 2019-12-31 | $-65.36 M | 58.91% |
| 2018-12-31 | $-41.13 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 17,730.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 3,152.63% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $0.85 B | 71.61% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.82 B | -263.46% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.36 B | -26.43% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $58.95 M | -88.23% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.38 B | -22.54% | 🇺🇸 USA |